These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 3052644)
1. Recent studies on perfluorochemical (PFC) emulsion as an oxygen carrier in Japan. Mitsuno T; Ohyanagi H; Yokoyama K; Suyama T Biomater Artif Cells Artif Organs; 1988; 16(1-3):365-73. PubMed ID: 3052644 [TBL] [Abstract][Full Text] [Related]
2. Present status of clinical studies of Fluosol-DA (20%) in Japan. Mitsuno T; Ohyanagi H Int Anesthesiol Clin; 1985; 23(1):169-84. PubMed ID: 3980104 [TBL] [Abstract][Full Text] [Related]
3. Development of a perfluorochemical emulsion as a blood gas carrier. Mitsuno T; Ohyanagi H; Yokoyama K Artif Organs; 1984 Feb; 8(1):25-33. PubMed ID: 6422912 [TBL] [Abstract][Full Text] [Related]
4. U.S. clinical studies of the treatment of anemia with fluosol-DA 20%. Tremper KK; Cullen BF Artif Organs; 1984 Feb; 8(1):19-24. PubMed ID: 6367719 [TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%). Tremper KK; Lapin R; Levine E; Friedman A; Shoemaker WC Crit Care Med; 1980 Dec; 8(12):738-41. PubMed ID: 7449405 [TBL] [Abstract][Full Text] [Related]
6. Experimental studies on fluosol DA administration in acute pancreatitis. Ohyanagi H; Ohashi O; Nakayama S; Yamamoto M; Okumura S; Saitoh Y Biomater Artif Cells Artif Organs; 1988; 16(1-3):585-94. PubMed ID: 3179491 [TBL] [Abstract][Full Text] [Related]
7. Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)--an overview of clinical studies with 185 patients. Suyama T; Yokoyama K; Naito R Prog Clin Biol Res; 1981; 55():609-28. PubMed ID: 7027272 [TBL] [Abstract][Full Text] [Related]
9. Perfluorochemical emulsion oxygen transport fluids: a clinical review. Tremper KK; Anderson ST Annu Rev Med; 1985; 36():309-13. PubMed ID: 3888055 [TBL] [Abstract][Full Text] [Related]
10. Development and clinical application of perfluorochemical artificial blood. Ohyanagi H; Saitoh Y Int J Artif Organs; 1986 Sep; 9(5):363-8. PubMed ID: 3781670 [TBL] [Abstract][Full Text] [Related]
12. [The place for using erythrocyte substitutes in hemodilution: fluosol-DA and polymerized pyridoxylated hemoglobin]. Vigneron C; Labrude P; Dellacherie E Ann Fr Anesth Reanim; 1986; 5(3):260-8. PubMed ID: 3535579 [TBL] [Abstract][Full Text] [Related]
14. The use of fluorocarbon emulsions in cancer radiotherapy. Guichard M Radiother Oncol; 1991; 20 Suppl 1():59-64. PubMed ID: 2020771 [TBL] [Abstract][Full Text] [Related]
16. A perfluorochemical emulsion as an oxygen carrier. Yokoyama K; Suyama T; Okamoto H; Watanabe M; Ohyanagi H; Saitoh Y Artif Organs; 1984 Feb; 8(1):34-40. PubMed ID: 6703924 [TBL] [Abstract][Full Text] [Related]
17. Use of perfluorochemical emulsions in cancer therapy. Teicher BA Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):875-82. PubMed ID: 1391527 [TBL] [Abstract][Full Text] [Related]
18. Effect of fluosol-DA infusion on pulmonary vascular permeability in the dog lung. Hall JE; Ehrhart IC; Hofman WF J Trauma; 1986 May; 26(5):432-7. PubMed ID: 3084806 [TBL] [Abstract][Full Text] [Related]
19. Perfluorocarbons as blood substitutes. Waxman K Ann Emerg Med; 1986 Dec; 15(12):1423-4. PubMed ID: 3777615 [TBL] [Abstract][Full Text] [Related]
20. Effect of oxygen level on the enhancement of tumor response to radiation by perfluorochemical emulsions or a bovine hemoglobin preparation. Teicher BA; Herman TS; Hopkins RE; Menon K Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):969-74. PubMed ID: 1917627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]